We confirmed these results by immunoblot analysis and showed a significant increase in the level of NuRD complex proteins in TMG treated breast cancer cells compared to controls with the exception of RBBP4 (Supplementary Figure S1A). The gene discussed is RBBP4; the disease is breast carcinoma.